Multiplexed detection and isolation of viable low-frequency cytokine-secreting human B cells using cytokine secretion assay and flow cytometry (CSA-Flow)

por Rezk, Ayman, Li, Rui, Bar-Or, Amit
Publicado 2020

Obituary: Ajit Dhaunchak, Ph.D

por De Faria, Omar, Bar-Or, Amit, Awasthi, Anshul
Publicado 2013

COVID-19 and MS disease-modifying therapies

por Berger, Joseph R., Brandstadter, Rachel, Bar-Or, Amit
Publicado 2020

Editorial: Update on Translational Neuroimmunology - Research of ISNI 2018

por Probert, Lesley, Quintana, Francisco J., Bar-Or, Amit
Publicado 2020

Sequencing the immunopathologic heterogeneity in multiple sclerosis

por Antel, Jack P, Ludwin, Samuel K, Bar-Or, Amit
Publicado 2015

Bruton tyrosine kinase inhibitors for multiple sclerosis

por Krämer, Julia, Bar-Or, Amit, Turner, Timothy J., Wiendl, Heinz
Publicado 2023

Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature

por Korsukewitz, Catharina, Reddel, Stephen W., Bar-Or, Amit, Wiendl, Heinz
Publicado 2020

Author Correction: Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature

por Korsukewitz, Catharina, Reddel, Stephen W., Bar-Or, Amit, Wiendl, Heinz
Publicado 2020

Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS Autoimmunity

por Pikor, Natalia B., Prat, Alexandre, Bar-Or, Amit, Gommerman, Jennifer L.
Publicado 2016

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

por Bar-Or, Amit, Pachner, Andrew, Menguy-Vacheron, Francoise, Kaplan, Johanne, Wiendl, Heinz
Publicado 2014

Réponses immunitaires au vaccin contre le virus SARS-CoV-2 et infections perthérapeutiques chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrélizumab (OCR)...

por Bar-Or, Amit, Bhargava, Pavan, Patti, Francesco, Killestein, Joep, Vollmer, Timothy, Kuenzel, Thomas, Lebrun, Christine
Publicado 2023

Erratum: microRNA dysregulation in multiple sclerosis

por Moore, Craig S., De Faria, Omar, Antel, Jack, Bar-Or, Amit, Kennedy, Timothy E., Dhaunchak, Ajit
Publicado 2013

B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation

por Michel, Laure, Touil, Hanane, Pikor, Natalia B., Gommerman, Jennifer L., Prat, Alexandre, Bar-Or, Amit
Publicado 2015

Distinct stage-specific transcriptional states of B cells derived from human tonsillar tissue

por Espinoza, Diego A., Le Coz, Carole, Cruz Cabrera, Emylette, Romberg, Neil, Bar-Or, Amit, Li, Rui
Publicado 2023

Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens

por Bar-Or, Amit, Wiendl, Heinz, Miller, Barry, Benamor, Myriam, Truffinet, Philippe, Church, Meg, Menguy-Vacheron, Francoise
Publicado 2015

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

por Bar-Or, Amit, O’Brien, Susan M., Sweeney, Michael L., Fox, Edward J., Cohen, Jeffrey A.
Publicado 2021

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide

por Tornatore, Carlo, Wiendl, Heinz, Lublin, Alex L., Geertsen, Svend S., Chavin, Jeffrey, Truffinet, Philippe, Bar-Or, Amit
Publicado 2022

MicroRNA dysregulation in multiple sclerosis

por Jr, Omar de Faria, Moore, Craig S., Kennedy, Timothy E., Antel, Jack P., Bar-Or, Amit, Dhaunchak, Ajit S.
Publicado 2013

Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone

por Evdoshenko, Evgeniy, Maslyanskiy, Alexey, Lapin, Sergey, Zaslavsky, Leonid, Dobson, Ruth, Totolian, Areg, Skoromets, Alexander, Bar-Or, Amit
Publicado 2013

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

por Li, Rui, Rezk, Ayman, Healy, Luke M., Muirhead, Gillian, Prat, Alexandre, Gommerman, Jennifer L., Bar-Or, Amit
Publicado 2016